Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 9/20 | 0.60 |
| ▸ | MMP2 | P08253 | 8/20 | 0.60 |
| ▸ | MMP1 | P03956 | 7/20 | 0.60 |
| ▸ | MMP8 | P22894 | 6/20 | 0.60 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.49 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7301335 | 1.00 | MMP9 (0.60) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL6418631 | 0.91 | MMP9 (0.51) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL6418630 | 0.91 | MMP9 (0.51) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL6418633 | 0.91 | MMP9 (0.51) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL7174229 | 0.85 | FFAR1 (0.52) | MMP9MMP2MMP1MMP8CTSD | |
| SCHEMBL7174233 | 0.85 | FFAR1 (0.52) | MMP9MMP2MMP1MMP8CTSD | |
| SCHEMBL21214681 | 0.83 | MMP9 (0.61) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL21214668 | 0.81 | MMP9 (0.59) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL21214688 | 0.81 | MMP9 (0.58) | MMP9MMP2MMP1MMP8ADAMTS4 | |
| SCHEMBL21214709 | 0.81 | MMP9 (0.58) | MMP9MMP2MMP1MMP8ADAMTS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0480714-A2 | HIV protease inhibitors having symmetrical structure | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | disclosed |